Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

The Wegovy pill’s ‘surprise miss’ is one reason Novo Nordisk’s stock is down

The Danish drugmaker also revealed an improved outlook for the year.

The Wegovy pill’s ‘surprise miss’ is one reason Novo Nordisk’s stock is down

Published August 4, 2026 · Category: Finance

Overview

The Danish drugmaker also revealed an improved outlook for the year.

Source

Originally published at www.marketwatch.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.